Hypertension in the Nursing Home

Journal of the American Medical Directors Association

Volumn 9, Issue 7, 2008, Pages 486-490

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

antihypertensive drugs; cardiovascular disease; coronary risk factors; elderly; Hypertension; nursing home patients

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; METOPROLOL; NITRENDIPINE; PERINDOPRIL; PLACEBO; PROPRANOLOL; RAMIPRIL; THIAZIDE DIURETIC AGENT; TIMOLOL;

ANGIONEUROTIC EDEMA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORONARY RISK; COUGHING; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG INDICATION; ELDERLY CARE; FRAIL ELDERLY; HEART INFARCTION; HUMAN; HYPERTENSION; MONOTHERAPY; NURSING HOME; REVIEW; STROKE; SYSTOLIC BLOOD PRESSURE; TASTE DISORDER;

EID: 50149102409     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2008.03.013     Document Type: Review

References (65)

1. Aronow W.S., Ahn C., and Gutstein H. Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility. J Gerontol A Bio Sci Med Sci 57A (2002) M45-M46
2. Mendelson G., Ness J., and Aronow W.S. Drug treatment of hypertension in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc 47 (1999) 597-599
3. Ziesmer V., Ghosh S., and Aronow W.S. Use of antihypertensive drug therapy in older persons in an academic nursing home. J Am Med Dir Assoc 3 (2002) 243-245
4. Martin-Baranera M., Sanchez Ferrin P., Armario P., and Geriatric HTA Study group. Prevalence of hypertension in elderly long-term care residents in Spain. The Geriatric HTA study. Med Clin (Barc) 127 (2006) 681-687
5. Thomas J.M., Alvarez W., Mulaj M., et al. Control of hypertension in nursing homes. Rev Med Brux 27 (2006) S271-S273
6. Koka M., Joseph J., and Aronow W.S. Adequacy of control of hypertension in an academic nursing home. J Am Med Dir Assoc 8 (2007) 538-540
7. 1c <7.0%, of a blood pressure <130/80 mm Hg, and of a serum low-density lipoprotein cholesterol <100 mg/dL in older patients with diabetes mellitus in an academic nursing home. J Am Med Dir Assoc 9 (2008) 51-54
8. Joseph J., Koka M., and Aronow W.S. Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke, and congestive heart failure in an academic nursing home. J Am Med Dir Assoc 9 (2008) 257-259
9. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program working group report on hypertension in the elderly. Hypertens 23 (1994) 275-285
10. Madhavan S., Ooi W.L., Cohen H., and Alderman M.H. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertens 23 (1994) 395-401
11. Aronow W.S., Ahn C., Kronzon I., and Koenigsberg M. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol 67 (1991) 295-299
12. Aronow W.S., and Ahn C. Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease. Am J Cardiol 77 (1996) 864-866
13. Joseph J., Koka M., and Aronow W.S. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home. J Am Med Dir Assoc 9 (2008) 124-127
14. Aronow W.S., Ahn C., and Gutstein H. Risk factors for new atherothrombotic brain infarction in 664 older men and 1,488 older women. Am J Cardiol 77 (1996) 1381-1383
15. Aronow W.S., and Frishman W.H. Treatment of hypertension and prevention of ischemic stroke. Current Cardiology Reports 6 (2004) 124-129
16. Aronow W.S., Ahn C., and Kronzon I. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 84 (1999) 611-612
17. Aronow W.S. Treatment of systolic and diastolic heart failure in the elderly. J Am Med Dir Assoc 7 (2006) 29-36
18. Aronow W.S., Sales F.F., Etienne F., and Lee N.H. Prevalence of peripheral arterial disease and its correlation with risk factors for peripheral arterial disease in elderly patients in a long-term health care facility. Am J Cardiol 62 (1988) 644-646
19. Aronow W.S., and Frishman W.H. Effect of antihypertensive drug treatment on cognitive function. Clin Geriatr 14 (2006) 25-28
20. Gandelman G., Aronow W.S., and Varma R. Prevalence of adequate blood pressure control in self-pay or Medicare patients versus Medicaid or private insurance patients with systemic hypertension followed in a university cardiology or general medicine clinic. Am J Cardiol 94 (2004) 815-816
21. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 289 (2003) 2560-2572
22. Progress Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
23. Forette F., Seux M.-L., Staessen J.A., et al. The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 162 (2002) 2046-2052
24. Murray M.D., Lane K.A., Gao S., et al. Preservation of cognitive function with antihypertensive medications. A longitudinal analysis of a community-based sample of African Americans. Arch Intern Med 162 (2002) 2090-2096
25. Veld B.A., Ruitenberg A., Holman A., et al. Antihypertensive drugs and incidence of dementia: The Rotterdam Study. Neurobiol Aging 22 (2001) 407-412
26. Gueyffier F., Bulpitt C., Boissel J.-P., et al. Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials. Lancet 353 (1999) 793-796
27. Aronow W.S. Drug therapy of older persons with hypertension. J Am Med Dir Assoc 7 (2006) 193-196
28. Hansson L., Zanchetti A., Carruthers S.G., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal result of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1755-1762
29. Mendelson G., Nassimiha D., and Aronow W.S. Simultaneous measurements of blood pressures in right and left brachial arteries. Cardiol Rev 12 (2004) 276-278
30. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 100 (1999) 1016-1030
31. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153
32. Aronow W.S., Ahn C., and Kronzon I. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction. Am J Cardiol 88 (2001) 1298-1300
33. Aronow W.S., and Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and diabetes mellitus. Am J Cardiol 87 (2001) 780-781
34. Aronow W.S., and Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol 87 (2001) 1284-1286
35. Pahor M., Psaty B.M., Alderman M.H., et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials. Lancet 356 (2000) 1949-1954
36. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 283 (2000) 1967-1975
37. Aronow W.S., and Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers. Am J Cardiol 89 (2002) 1207-1209
38. Bryson C.L., Smith N.L., Kuller L.H., et al. Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists. J Am Geriatr Soc 52 (2004) 1648-1654
39. Kennedy H.L., Brooks M.M., Barker A.H., et al. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol 74 (1994) 674-680
40. Aronow W.S., Ahn C., Mercando A.D., et al. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%. Am J Cardiol 74 (1994) 267-270
41. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
42. Aronow W.S., Ahn C., and Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% treated with diuretics plus angiotensin-converting-enzyme inhibitors. Am J Cardiol 80 (1997) 207-209
43. Aronow W.S., and Frishman W.H. Angina in the elderly. In: Aronow W.S., Fleg J.L., and Rich M.W. (Eds). Cardiovascular Disease in the Elderly. 4th ed. (2008), Informa Healthcare, New York, NY 269-292
44. Aronow W.S., Ahn C., Mercando A.D., et al. Decrease of mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect. Am J Cardiol 74 (1994) 613-615
45. Aronow WS. Treatment of atrial fibrillation. Part 1. Cardiol Rev. Accepted for publication.
46. Aronow WS. Treatment of atrial fibrillation. Part 2. Cardiol Rev. Accepted for publication.
47. Aronow W.S. The heart and thyroid disease. In: Gambert S.R. (Ed). Clinics in Geriatric Medicine. Thyroid Disease (1995), W.B. Saunders Co, Philadelphia, PA 219-229
48. Aronow W.S. Might losartan reduce sudden cardiac death in diabetic patients with hypertension?. Lancet 362 (2003) 591-592
49. Carlberg B., Samuelsson O., and Lindholm L.H. Atenolol in hypertension: Is it a wise choice?. Lancet 364 (2004) 1684-1689
50. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the International Society for Heart and Lung Transplantation. Endorsed by the Heart Failure Society of America. J Am Coll Cardiol 38 (2001) 2101-2113
51. Aronow W.S. Treatment of heart failure with abnormal left ventricular systolic function in the elderly. In: Aronow W.S. (Ed). Clinics in Geriatric Medicine. Heart Failure 23 (2007), Elsevier, Philadelphia, PA 61-81
52. Agodoa L.Y., Appel L., Bakris G.L., et al. Effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial. JAMA 285 (2001) 2719-2728
53. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 (2001) 861-869
54. Grundy S.M., Cleeman J.I., Merz C.N.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
55. Aronow W.S. Updated National Cholesterol Education Program III guidelines. J Am Med Dir Assoc 6 (2005) 160-161
56. Zarowitz B.J., Aronow W.S., Hollenack K., and O'Shea T. The application of evidence-based principles of care in older persons (issue 2): Management of lipid disorders. J Am Med Dir Assoc 7 (2006) 173-179
57. Aronow W.S. Managing hyperlipidaemia in the elderly. Special considerations for a population at high risk. Drugs Aging 23 (2006) 181-189
58. Koka M., Joseph J., and Aronow W.S. Prevalence of adequate and of optimal control of serum low-density lipoprotein cholesterol in an academic nursing home. J Am Med Dir Assoc 8 (2007) 604-606
59. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 26 (2003) 533-550
60. Smith Jr. S.C., Allen J., Blair S.N., et al. ACC/AHA guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
61. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321 (2000) 405-412
62. 1c level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol 97 (2006) 968-969
63. 1c levels to severity of peripheral arterial disease in patients with diabetes mellitus. Am J Cardiol 99 (2007) 1468-1469
64. Chiong J.R., Aronow W.S., Khan I.A., et al. Secondary hypertension: Current diagnosis and treatment. Int J Cardiol 124 (2008) 6-21
65. Aronow W.S. Dizziness and syncope. In: Hazzard W.R., Blass J.P., Ettinger Jr. W.H., et al. (Eds). Principles of Geriatric Medicine and Gerontology. 4th ed. (1998), McGraw-Hill, Inc, New York, NY 1519-1534